Ceftazidime in the therapy of chronic bronchitis relapses in elderly hospitalized patients

We studied the clinical and bacteriological efficacy and the safety of ceftazidime in elderly patients suffering from recurrent chronic bronchitis. 33 hospitalized subjects (10 F. 23 M: mean age 78.5 +/- 6 yrs) were treated with ceftazidime (1 g b.i.d.) for a mean of 9 +/- 1.5 days. At the end of treatment all patients had positive clinical results, with bacteriological eradication equal to 95%. Only one case of relapse was observed at the follow up assessment. As to safety only one case of vomiting was observed (but did not require treatment withdrawal).